Tumor microenvironment-driven drug resistance in urologic cancers: mechanisms and therapeutic targets.

Therapeutic resistance remains a major challenge in the management of urologic cancers, including renal cell carcinoma (RCC), bladder cancer (BC), and prostate cancer (PCa). Recent advances highlight the tumor microenvironment (TME) as a critical det…

Preview only. Read the full abstract at the source